UK markets close in 29 minutes

Biophytis S.A. (BPTS)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
10.17-0.02 (-0.16%)
As of 10:14AM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 3.05M
Enterprise value 3.21M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)2.26
Enterprise value/revenue N/A
Enterprise value/EBITDA -0.21

Trading information

Stock price history

Beta (5Y monthly) 1.05
52-week change 3-92.28%
S&P500 52-week change 325.01%
52-week high 3168.80
52-week low 38.47
50-day moving average 316.64
200-day moving average 336.18

Share statistics

Avg vol (3-month) 38.96k
Avg vol (10-day) 37.73k
Shares outstanding 5286.5k
Implied shares outstanding 65.66M
Float 81.11B
% held by insiders 1N/A
% held by institutions 1N/A
Shares short (28 Mar 2024) 41.07k
Short ratio (28 Mar 2024) 40.59
Short % of float (28 Mar 2024) 4N/A
Short % of shares outstanding (28 Mar 2024) 40.02%
Shares short (prior month 29 Feb 2024) 4743

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:40
Last split date 323 Apr 2024

Financial highlights

Currency in EUR.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-52.78%
Return on equity (ttm)N/A

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -13.8M
Net income avi to common (ttm)-17.03M
Diluted EPS (ttm)-127.89
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)5.57M
Total cash per share (mrq)0
Total debt (mrq)8.27M
Total debt/equity (mrq)N/A
Current ratio (mrq)0.72
Book value per share (mrq)-0.00

Cash flow statement

Operating cash flow (ttm)-12.87M
Levered free cash flow (ttm)-5.66M